Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smoking cessation study

This article was originally published in The Tan Sheet

Executive Summary

Nicotine replacement therapy with OTC gum or patch "at least" as good as Rx treatment, study conducted by Saul Shiffman, MD, University of Pittsburgh, et al., concludes. Published in May issue of Addiction, research involved contrasting data from parallel, independent studies assessing usage, outcomes from GlaxoSmithKline's Nicorette gum and NicoDerm CQ patch in simulated OTC and "real world" Rx settings. Abstinence after six weeks and six months of treatment was compared. The OTC evaluation enrolled 5,348 smokers, while Rx use information was obtained from 933 smokers who had filed prescriptions for treatments...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093978

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel